Lowell E. Schnipper

11.2k total citations · 4 hit papers
120 papers, 7.2k citations indexed

About

Lowell E. Schnipper is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lowell E. Schnipper has authored 120 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 32 papers in Molecular Biology and 31 papers in Epidemiology. Recurrent topics in Lowell E. Schnipper's work include Herpesvirus Infections and Treatments (23 papers), Economic and Financial Impacts of Cancer (19 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Lowell E. Schnipper is often cited by papers focused on Herpesvirus Infections and Treatments (23 papers), Economic and Financial Impacts of Cancer (19 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Lowell E. Schnipper collaborates with scholars based in United States, United Kingdom and Belgium. Lowell E. Schnipper's co-authors include Anthony Elias, Clyde S. Crumpacker, Thomas J. Smith, Clyde S. Crumpacker, Therese M. Mulvey, Dana S. Wollins, Karen H. Antman, Emil Frei, Myron J. Levin and Joseph P. Eder and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Lowell E. Schnipper

118 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression

1988 538 citations Karen Antman, James D. Griffin et al. New England Journal of Medicine profile →
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care

2009 482 citations Lowell E. Schnipper et al. Journal of Clinical Oncology profile →
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology

2012 458 citations Lowell E. Schnipper et al. Journal of Clinical Oncology profile →
American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer

2011 388 citations Lowell E. Schnipper et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Lowell E. Schnipper

Since Specialization

Citations

This map shows the geographic impact of Lowell E. Schnipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lowell E. Schnipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lowell E. Schnipper more than expected).

Fields of papers citing papers by Lowell E. Schnipper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lowell E. Schnipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lowell E. Schnipper. The network helps show where Lowell E. Schnipper may publish in the future.

Co-authorship network of co-authors of Lowell E. Schnipper

This figure shows the co-authorship network connecting the top 25 collaborators of Lowell E. Schnipper. A scholar is included among the top collaborators of Lowell E. Schnipper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lowell E. Schnipper. Lowell E. Schnipper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection—case report and review of the literature 2003 ·Annals of Hematology ·Balázs Halmos, Harry T. Anastopoulos, Lowell E. Schnipper, Enrique Ballesteros	7
2	Cancer survivorship issues for minority and underserved populations. 2003 ·PubMed ·Timothy D. Gilligan, (unknown), (unknown), (unknown), Lowell E. Schnipper, Frederick P. Li	5
3	Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors 1998 ·Cancer ·David Avigan, Paul G. Richardson, Anthony Elias, George D. Demetri, Michael Shapiro, Lowell E. Schnipper, Catherine Wheeler	28
4	Genetic analysis of adenovirus E1A: induction of genetic instability and altered cell morphologic and growth characteristics are segregatable functions 1998 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Reed E. Drews, (unknown), (unknown), (unknown), Victor Chan, Lowell E. Schnipper	4
5	Cloning and characterization of the 5′-flanking sequence for the human DNA topoisomerase II beta gene 1997 ·Gene ·Shu‐Wing Ng, Yan Liu, Lowell E. Schnipper	12
6	A model state Act to authorize and regulate physician-assisted suicide. 1996 ·PubMed ·(unknown), (unknown), Dan W. Brock, (unknown), Nancy S. Dorfman, Judith A. Johnson, Lowell E. Schnipper, (unknown), (unknown)	33
7	Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. 1995 ·Journal of Clinical Oncology ·Lois Ayash, C Wheeler, Diane L. Fairclough, (unknown), E Reich, D Warren, Lowell E. Schnipper, Karen H. Antman, E Frei, Alby Elias	99
8	Effect of recombinant human interleukin‐3 on haematological recovery from chemotherapy‐induced myelosuppression 1994 ·British Journal of Haematology ·I Tepler, Anthony Elias, Leslie A. Kalish, Lawrence N. Shulman, Gary M. Strauss, Arthur T. Skarin, Thomas J. Lynch, Daniel Levitt, Debra Resta, G. D. Demetri, (unknown), Lowell E. Schnipper	14
9	High-Dose Chemotherapy with Autologous Stem Cell Support for Breast Cancer: A Review of the Dana-Farber Cancer Institute/Beth Israel Hospital Experience 1993 ·Journal of Hematotherapy ·Lois Ayash, Anthony Elias, Catherine Wheeler, Isidore Tepler, Gary N. Schwartz, Lowell E. Schnipper, Emil Frei, Karen H. Antman	3
10	The Use of G-CSF or GM-CSF Mobilized Peripheral Blood Progenitor Cells (PBPC) Alone or to Augment Marrow as Hematologic Support of Single or Multiple Cycle High-Dose Chemotherapy 1993 ·Journal of Hematotherapy ·Anthony Elias, Lois Ayash, I Tepler, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, Lowell E. Schnipper, E Frei, Karen H. Antman	8
11	High-Dose Combined Alkylating Agent Therapy With Autologous Stem Cell Support and Chest Radiotherapy for Limited Small-Cell Lung Cancer 1993 ·CHEST Journal ·Anthony Elias, Lois Ayash, Arthur T. Skarin, C Wheeler, Gary N. Schwartz, Rosemary Mazanet, Isidore Tepler, Lowell E. Schnipper, E Frei, Karen H. Antman	8
12	A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. 1992 ·Journal of Clinical Oncology ·Karen H. Antman, Lois Ayash, Anthony Elias, Catherine Wheeler, M Hunt, Joseph P. Eder, Beverly A. Teicher, J.D. Critchlow, (unknown), Lowell E. Schnipper	313
13	Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung 1991 ·Cancer ·Catherine Wheeler, Lawrence N. Shulman, Steven E. Come, Lowell E. Schnipper, Thomas J. Ervin	4
14	A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients 1991 ·Cancer Chemotherapy and Pharmacology ·Joseph P. Eder, Anthony Elias, Lois Ayash, Catherine Wheeler, Thomas C. Shea, Lowell E. Schnipper, E Frei, Karen H. Antman	6
15	Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study 1991 ·Journal of Cancer Research and Clinical Oncology ·Anthony Elias, Lois Ayash, J. P. Eder, C Wheeler, (unknown), (unknown), M Hunt, (unknown), Lowell E. Schnipper, E Frei, Karen H. Antman	6
16	Bone marrow autotransplantation for solid tumors--prospects. 1989 ·Journal of Clinical Oncology ·Emil Frei, Karen H. Antman, Beverly A. Teicher, Piotr Eder, Lowell E. Schnipper	134
17	A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. 1989 ·Journal of Clinical Oncology ·Thomas C. Shea, (unknown), Alby Elias, (unknown), Karen H. Antman, Colin B. Begg, Lowell E. Schnipper, E Frei, W. David Henner	155
18	Cyclophosphamide and Thiotepa With Autologous Bone Marrow Transplantation in Patients With Solid Tumors 1988 ·JNCI Journal of the National Cancer Institute ·Joseph P. Eder, Karen H. Antman, Anthony Elias, Thomas C. Shea, Beverly A. Teicher, W. David Henner, S Schryber, Sylvia A. Holden, Robert W. Finberg, (unknown), Mary Flaherty, Rosemarie Mick, Lowell E. Schnipper, Emil Frei	42
19	Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression breakdown → 1988 ·New England Journal of Medicine ·Karen Antman, James D. Griffin, Anthony Elias, Mark A. Socinski, Louise Ryan, Stephen A. Cannistra, Dagmar Oette, (unknown), Emil Frei, Lowell E. Schnipper	538
20	Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulogytic leukemia 1972 ·Cancer ·George P. Canellos, Jacqueline Whang‐Peng, Lowell E. Schnipper, Clarence H. Brown	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact